Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Lactate reprograms PGE2 metabolism via GPR81 inhibits COX2 to relieved psoriasis.

Scientific reports·2026
Same author

Targeting chitinase-3-like protein 2 (CHI3L2) suppresses cell proliferation and migration in glioblastoma.

Translational cancer research·2026
Same author

VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses.

Journal of neuroinflammation·2025
Same author

An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity.

Neoplasia (New York, N.Y.)·2025
Same author

A review for the impacts of circadian disturbance on urological cancers.

Sleep and biological rhythms·2024
Same author

Microfluidic-based preparation of artificial antigen-presenting gel droplets for integrated and minimalistic adoptive cell therapy strategies.

Biofabrication·2024

相关实验视频

Updated: Jul 24, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

微流体芯片:用于采用细胞免疫治疗的新兴技术

Yishen Tian1, Rong Hu1, Guangshi Du1

  • 1Translational Medicine Research Center, Guizhou Medical University, Guiyang 550025, China.

Micromachines
|July 8, 2023
PubMed
概括
此摘要是机器生成的。

微流体芯片通过有效的细胞隔离,查和培养来简化采用细胞疗法 (ACT) 准备. 这项技术为各种癌症提供了更快,更具成本效益和个性化的ACT方法.

关键词:
采用细胞疗法采用细胞疗法细胞正在扩张,细胞正在扩张.细胞分类 细胞分类免疫疗法 免疫疗法这是一个微流体芯片.

更多相关视频

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.0K

相关实验视频

Last Updated: Jul 24, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
05:58

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells

Published on: October 13, 2023

1.3K
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
15:41

A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells

Published on: October 15, 2013

15.0K

科学领域:

  • 生物技术和生物医学工程 生物技术和生物医学工程
  • 细胞和分子医学是细胞和分子医学.
  • 癌症治疗 癌症治疗

背景情况:

  • 采用细胞疗法 (ACT) 对血液性恶性瘤和固体瘤有希望.
  • 目前的ACT准备是复杂的,耗时的,昂贵的,在细胞准备方面面临挑战.
  • 微流体技术在微/纳米尺度上提供精确的流体操纵.

研究的目的:

  • 审查微流体芯片在采用细胞治疗中的优势和应用.
  • 将微流体方法与现有的细胞分类,查和ACT培养技术进行比较.
  • 讨论ACT中微流体的挑战和未来潜力.

主要方法:

  • 对微流体在细胞分类,查和培养中的应用进行现有文献的审查.
  • 分析微流体芯片的优点:高吞吐量,低细胞损伤,快速放大.
  • 微流体与ACT准备常规方法的比较.

主要成果:

  • 微流体芯片可以显著简化ACT准备步骤,减少时间和成本.
  • 该技术促进高通量细胞隔离,选和化,细胞损伤最小.
  • 可定制的微流体芯片与ACT的个性化特性保持一致.

结论:

  • 微流体学为推进采用细胞疗法提供了一个强大的平台.
  • 该技术解决了ACT准备的关键挑战,提高了效率和个性化.
  • 进一步的研究和开发为微流体在临床ACT应用中的巨大潜力.